Gliadorphin
 | |
| Names | |
|---|---|
| IUPAC name
L-Tyrosyl-L-prolyl-L-glutaminyl-L-prolyl-L-glutaminyl-L-prolyl-L-phenylalanine | |
| Other names
Gluteomorphin; Gliadorphin-7 | |
| Identifiers | |
| 107936-65-2 | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 115783 |
| PubChem | 130932 |
| |
| |
| Properties | |
| C43H57N9O11 | |
| Molar mass | 875.98 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Gliadorphin (also known as gluteomorphin) is an opioid peptide that is formed during digestion of the gliadin component of the gluten protein. It is usually broken down into amino acids by digestion enzymes. It has been hypothesized that children with autism have abnormal leakage from the gut of this compound. This is partly the basis for the gluten-free, casein-free diet. Studies of this diet have had important methodological flaws, and the scientific evidence is not adequate to make treatment recommendations. However, abnormally high levels of gliadorphin have been found in the urine of autistic children via mass spectrometry testing. [1]
References
- ↑ Christison GW, Ivany K (2006). "Elimination diets in autism spectrum disorders: any wheat amidst the chaff?". J Dev Behav Pediatr. 27 (2 Suppl 2): S162–71. doi:10.1097/00004703-200604002-00015. PMID 16685183.
This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.